Cognitive Rehabilitation for Depression
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help Veterans who have received treatment for major depressive disorder (MDD) but continue to experience thinking and memory problems. It will test whether an 8-week program called Motivationally Enhanced Compensatory Cognitive Training (ME-CCT-MDD) can improve their mental skills and quality of life. Participants will be randomly assigned to either this program or a similar one focused on setting and achieving goals, known as Goal-focused Supportive Contact. Veterans treated for MDD in the past year who have ongoing memory or attention issues might be a good fit for this trial. As an unphased trial, it offers Veterans the chance to explore innovative approaches to enhance mental skills and quality of life.
Do I need to stop my current medications to join the trial?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the study staff or your healthcare provider.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that Motivationally Enhanced Compensatory Cognitive Training for Major Depressive Disorder (ME-CCT-MDD) is generally safe and well-tolerated. Studies have found that similar programs improve attention, memory, and overall thinking skills without causing serious side effects. Participants often notice better daily functioning and mental performance.
As a non-drug treatment, ME-CCT-MDD doesn't carry the same risks as medication. It focuses on teaching ways to handle stress and enhance thinking skills, minimizing the risk of negative physical effects. The main goal is to address thinking problems that may persist after depression treatment, without causing harm.
Overall, current research suggests that this training is safe for people with depression. Participants usually find it helpful and easy to manage. While no treatment is completely without risk, existing studies indicate that ME-CCT-MDD appears to be safe.12345Why are researchers excited about this trial?
Researchers are excited about Motivationally Enhanced Compensatory Cognitive Training for Major Depressive Disorder (ME-CCT-MDD) because it takes a unique approach by focusing on improving cognitive functioning in individuals with depression, particularly Veterans. Unlike standard treatments for depression, which often involve medication or general talk therapy, ME-CCT-MDD combines motivational techniques with cognitive training in a structured group setting. This method not only aims to alleviate depressive symptoms but also targets cognitive complaints, which are often overlooked in traditional therapies. Meanwhile, Goal-focused Supportive Contact (GSC) offers a comparable group therapy experience, emphasizing consistent support and interaction, which is essential for many individuals dealing with depression. The hope is that these innovative approaches will provide more comprehensive and effective support for those with Major Depressive Disorder.
What evidence suggests that this trial's treatments could be effective for depression-related cognitive deficits?
Research has shown that Motivationally Enhanced Compensatory Cognitive Training for Major Depressive Disorder (ME-CCT-MDD), a treatment tested in this trial, can significantly improve cognitive skills such as memory and attention in individuals with depression. Studies indicate that this training leads to moderate improvements in decision-making, learning new information, and memory retention. It may also reduce depression severity and enhance overall quality of life. This method addresses challenges that can hinder recovery from depression. Overall, early evidence suggests ME-CCT-MDD can effectively aid those experiencing cognitive difficulties due to depression.23678
Who Is on the Research Team?
Maya O'Neil, PhD
Principal Investigator
Portland VA Medical Center
Joren Adams
Principal Investigator
Portland VA Medical Center
Are You a Good Fit for This Trial?
This trial is for Veterans who have been treated for Major Depressive Disorder (MDD) within the past year and are still struggling with cognitive issues like memory and concentration. Participants must be willing to undergo assessments, attend weekly group sessions for 8 weeks, and complete follow-up evaluations.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo an assessment of cognition, symptoms, and functioning, including interviews and neuropsychological tests
Treatment
Participants receive either ME-CCT-MDD or GSC intervention, involving weekly group sessions for cognitive training or supportive contact
Follow-up
Participants complete a follow-up assessment of cognition, symptoms, and functioning, including a brief interview about their experience
What Are the Treatments Tested in This Trial?
Interventions
- Goal-focused Supportive Contact
- Motivationally Enhanced Compensatory Cognitive Training for Major Depressive Disorder (ME-CCT-MDD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Portland VA Medical Center
Lead Sponsor
Oregon Health and Science University
Collaborator